Talkiatry vs Regeneron Pharmaceuticals
Side-by-side comparison of AI visibility scores, market position, and capabilities
Raised $210M oversubscribed Series D (Feb 2026) led by Perceptive. $400M total. Largest private employer of psychiatrists in the US. 800+ MDs, 170M covered lives.
About
Talkiatry is the largest private employer of psychiatrists in the United States, with over 800 full-time psychiatrists providing in-network psychiatric care to patients across 170 million covered lives. The company raised an oversubscribed $210 million Series D in February 2026 led by Perceptive Advisors, bringing total funding to $400 million. Revenue grew 1,745% from 2021 to 2024, making Talkiatry the most scaled pure-play psychiatric provider in digital health.
Regeneron (REGN) reported $13.9B revenue in FY2024, up 7% YoY. Top biotech company. Dupixent franchise >$14B. Leaders in eye disease, immunology, oncology. HQ: Tarrytown, NY.
About
Regeneron Pharmaceuticals, Inc. is a leading biotechnology company specializing in the discovery, development, and commercialization of medicines for serious diseases, headquartered in Tarrytown, New York. Founded in 1988 by Leonard Schleifer and George Yancopoulos, Regeneron developed its own proprietary drug discovery technology platform (VelociGene, VelocImmune) that has enabled the development of multiple breakthrough medicines. The company reported revenues of $13.9B in FY2024, up 7% year-over-year.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.